New RSV mRNA trial recruiting babies for “investigational vaccines”

5-7 month old babies are being recruited for the Rhyme trial to test new “investigational vaccines” called mRNA-1345 and mRNA-1365. The viruses being targeted by Moderna are RSV (respiratory syncytial virus) and hMPV (human metapneumovirus). Is focusing efforts on developing new pharmaceutical agents the ticket to better resilience against infectious disease and better health? Or should the focus of attention be lifestyle changes including key aspects such as improving nutrition? What is the most effective path to better health?

Moderna and UK government 10 year mRNA research and development partnership: https://www.gov.uk/government/news/uk-cements-10-year-partnership-with-moderna-in-major-boost-for-vaccines-and-research

BMJ article on deputy chief medical officer for England during the covid pandemic joining Moderna as a clinical advisor: https://www.bmj.com/content/382/bmj.p1927

Moderna’s statement on their commitment to researching mRNA-based vaccines and therapies: https://trials.modernatx.com